Naveen L. Pereira, M.D.

"Clinical practice makes one realize the strengths and limitations of the treatments we render to patients," says Naveen L. Pereira, M.D., of Mayo Clinic in Rochester, Minn. He chose to study clinical and translational research in an effort to overcome these limitations and enhance and improve overall patient care.

His research focuses on individualized medicine, specifically in the area of pharmacogenomics — the field that tries to identify and compensate for genetic differences in individuals that result in varied responses to a single drug.

Dr. Pereira is studying the natriuretic peptide system in order to find ways to identify individualized biomarkers of common diseases, such as hypertension and heart failure. This will enable him and his fellow physicians to maximize efficacy and minimize adverse events for patients by tailoring the appropriate therapy to the specific patient.

As a clinician, Dr. Pereira is excited to have protected research time. In addition, he's looking forward to further training in the complex, multidisciplinary field of pharmacogenomics. Being able to access integrated resources in disciplines, such as statistical genetics, laboratory-based functional genomics and cardiorenal physiology, is one of the key benefits of Mayo's KL2 Program, he says.

See Dr. Pereira's publications on PubMed.


  • April 20, 2012
  • PRO297623